Meegada Sreenath, Akbar Hamza, Siddamreddy Suman, Casement David, Verma Rajanshu
Internal Medicine, The University of Texas Health Science Center/Christus Good Shepherd Medical Center, Longview, USA.
Medicine, University of Texas at Dallas, Dallas, USA.
Cureus. 2020 Feb 13;12(2):e6981. doi: 10.7759/cureus.6981.
Granulomatous myositis is a rare disease that predominantly results in proximal muscle weakness in the upper and/or lower extremities. As it can resemble other inflammatory myopathies, it is important to obtain a muscle biopsy to make the underlying diagnosis. We report the first case of granulomatous myositis associated with extremely elevated anti-striated muscle antibodies in a 69-year-old Caucasian woman. Granulomatous myositis has been associated with various autoimmune, infectious, rheumatologic, vasculitis, and oncologic disorders, and several antibodies have previously been reported to be associated with it. However, to the best of our knowledge, this is the first report where extremely elevated anti-striated muscle antibodies were found to be associated with granulomatous myositis in the absence of myasthenia gravis. The treatment of granulomatous myositis revolves around the use of corticosteroids, steroid-sparing immunosuppressive agents, and newer biologics.
肉芽肿性肌炎是一种罕见疾病,主要导致上肢和/或下肢近端肌无力。由于它可能类似于其他炎性肌病,因此进行肌肉活检以做出明确诊断很重要。我们报告了首例69岁白种女性肉芽肿性肌炎合并抗横纹肌抗体极度升高的病例。肉芽肿性肌炎与各种自身免疫性、感染性、风湿性、血管炎和肿瘤性疾病有关,此前已有几种抗体被报道与之相关。然而,据我们所知,这是首例在无重症肌无力的情况下发现抗横纹肌抗体极度升高与肉芽肿性肌炎相关的报告。肉芽肿性肌炎的治疗主要围绕使用皮质类固醇、类固醇节省型免疫抑制剂和新型生物制剂展开。